Connect Biopharma Holdings Limited
CNTB
$2.05
-$0.10-4.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.39% | -18.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.69% | -24.47% | |||
| Operating Income | -17.27% | 19.37% | |||
| Income Before Tax | -25.70% | 11.59% | |||
| Income Tax Expenses | 1.85% | -33.74% | |||
| Earnings from Continuing Operations | -25.57% | 11.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.57% | 11.74% | |||
| EBIT | -17.27% | 19.37% | |||
| EBITDA | -17.55% | 19.69% | |||
| EPS Basic | -25.22% | 11.83% | |||
| Normalized Basic EPS | -25.30% | 14.83% | |||
| EPS Diluted | -25.22% | 12.33% | |||
| Normalized Diluted EPS | -25.30% | 14.83% | |||
| Average Basic Shares Outstanding | 0.26% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.26% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||